Farringdon Capital’s Eastman Chemical EMN Stock Holding History

Farringdon Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,956	Closed	-$2.39M	–	505
2025 Q2	$2.39M	Buy	+31,956	New	+$2.51M	0.8%	12

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Farringdon Capital's EMN Position: Q3 2025 in Review

Farringdon Capital sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 31,956 shares — an estimated $2.39M sold.

Farringdon Capital first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $2.39M in Q2 2025. 662 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

Farringdon Capital reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
Farringdon Capital sold 31,956 Eastman Chemical shares in Q3 2025, an estimated $2.39M.
Farringdon Capital first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
Farringdon Capital's Eastman Chemical position peaked at $2.39M in Q2 2025.
662 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Farringdon Capital's 13F filing for Q3 2025, filed 13 Nov 2025.